Literature DB >> 26279728

Bladder leiomyosarcoma in a patient with chronic ketamine abuse: A case report.

Dewen Zhong1, Feng Yu1, Jiande Chen1, Chaolu Lin1, Huaijing Luo1.   

Abstract

Bladder leiomyosarcoma is a rare mesenchymal tumour, accounting for less than 0.5% of all primary bladder malignancies. Adult women of reproductive age have the higher incidence of bladder leiomyosarcoma. Exposure to local pelvic radiotherapy or systemic chemotherapy, especially cyclophosphamide therapy, is also a significant risk factor. We describe a case of a 31-year-old male who developed urinary bladder leiomyosarcoma. The patient had no history of radiotherapy, systemic chemotherapy, or other significant event, except a 5-year history of ketamine abuse. The tumour was found on the left bladder wall and was definitively diagnosed by transurethral resection of the bladder tumour. A partial cystectomy was performed. There are no known reports of urinary bladder leiomyosarcoma associated with chronic ketamine abuse; therefore, we speculate that chronic ketamine abuse may be a factor in the development of this infrequent bladder malignancy.

Entities:  

Year:  2015        PMID: 26279728      PMCID: PMC4514504          DOI: 10.5489/cuaj.2662

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  12 in total

Review 1.  From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine.

Authors:  Ornella Corazza; Sulaf Assi; Fabrizio Schifano
Journal:  CNS Neurosci Ther       Date:  2013-02-20       Impact factor: 5.243

2.  Leiomyosarcoma of the urinary bladder after cyclophosphamide.

Authors:  J Pedersen-Bjergaard; V Jønsson; M Pedersen; K Hou-Jensen
Journal:  J Clin Oncol       Date:  1995-02       Impact factor: 44.544

3.  Bladder leiomyosarcoma and pelvic fibroblastic tumor following cyclophosphamide therapy.

Authors:  R G Rowland; J N Eble
Journal:  J Urol       Date:  1983-08       Impact factor: 7.450

4.  A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma.

Authors:  S X Liang; Y Lakshmanan; B A Woda; Z Jiang
Journal:  Arch Pathol Lab Med       Date:  2001-09       Impact factor: 5.534

5.  Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series.

Authors:  R S C Lo; R Krishnamoorthy; J G Freeman; A S Austin
Journal:  Singapore Med J       Date:  2011-03       Impact factor: 1.858

Review 6.  Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas.

Authors:  Dipen J Parekh; Charlie Jung; Jeffery O'Conner; Sajal Dutta; Ernest R Smith
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

7.  Ketamine-associated ulcerative cystitis: a new clinical entity.

Authors:  Rohan Shahani; Cathy Streutker; Brendan Dickson; Robert J Stewart
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

8.  Spindle cell cancer of bladder during cyclophosphamide therapy for Wegener's granulomatosis.

Authors:  S B Chasko; J G Keuhnelian; W T Gutowski; G F Gray
Journal:  Am J Surg Pathol       Date:  1980-04       Impact factor: 6.394

Review 9.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

10.  Rapid progression of a urinary bladder leiomyosarcoma: report of a case.

Authors:  Toru Yamada; Shingo Nagai; Yusuke Kanimoto
Journal:  Case Rep Urol       Date:  2011-07-06
View more
  2 in total

1.  Giant Leiomyosarcoma of the Urinary Bladder.

Authors:  José G A Ribeiro; Carlos A B Klojda; Claudio P De Araújo; Lucas A S Pires; Marcio A Babinski
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  [Leiomyosarcoma of the urinary bladder treated using laparoscopic cystectomy and bladder replacement by enterocystoplasty: about a case].

Authors:  Dimitri Mbethe; Said Moudouni; Zacharia Dahami; Mohamed Amine Lakmichi; Ismael Sarf
Journal:  Pan Afr Med J       Date:  2017-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.